Gram negative bacteraemia - are they preventable and what will E. coli surveillance add?

Journal of Infection Prevention

Volumn 14, Issue 2, 2013, Pages 54-59

  Enoch, David A ^a   Mlangeni, Dennis A ^a   Ekundayo, James ^b   Aliyu, Muktar ^c   Sismey, Andrew W ^a   Aliyu, Sani H ^d   Karas, Andreas ^d  

^a PETERBOROUGH CITY HOSPITAL   (United Kingdom)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

bacteraemia; E. coli; Gram negative bacteraemia; surveillance

Indexed keywords

EID: 84874399047     PISSN: 17571774     EISSN: 17571782     Source Type: Journal    
DOI: 10.1177/1757177412470014     Document Type: Article

References (14)

1. Albrecht SJ,Fishman NO,Kitchen J,Nachamkin I,Bilker WB,Hoegg C,Samel C,Barbagallo S,Arentzen J,Lautenbach E.Reemergence of gram-negative health care-associated bloodstream infections.Archives of Internal Medicine. 2006;166:1289-94.
2. Bonnal C,Mourvillier B,Bronchard R,de Paula D,Armand-Lefevre L,L'heriteau F,Quenon JL,Lucet JC.Prospective assessment of hospital-acquired bloodstream infections: how many may be preventable?.BMJ Quality & Safety. 2010;19:e30.
3. D'Agata EM.Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: a 9-year surveillance study.Infection Control & Hospital Epidemiology. 2004;25:842-6.
4. Enoch DA,Phillimore N,Mlangeni DA,Salihu HM,Sismey A,Aliyu SH,Karas JA.Outcome for Gram-negative bacteraemia when following restrictive empirical antibiotic guidelines.Quarterly Journal of Medicine. 2011;104:411-19.
5. Enoch DA,Brown F,Sismey AW,Mlangeni DA,Curran MD,Karas JA,Cone DB,Aliyu SH,Dhanji H,Doumith M,Maharjan S,Meunier D,Woodford N.Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a UK district hospital; an observational study.Journal of Hospital Infection. 2012;81:270-7.
6. Harm Free Care. 2012. http://harmfreecare.org (accessed 25 October 2012).
7. Health Protection Agency. Escherichia coli bacteraemia in England, Wales and Northern Ireland, 2007-2011. HPA, 2012. www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317134482059 (accessed 28 October 2012).
8. Kang CI,Kim SH,Park WB,Lee KD,Kim HB,Kim EC,Oh MD,Choe KW.Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.Antimicrobial Agents & Chemotherapy. 2005;49:760-6.
9. Melzer M,Welch C.Is Escherichia coli bacteraemia preventable?.Lancet Infectious Diseases. 2012;12:103-4.
10. Micek ST,Lloyd AE,Ritchie DJ,Reichley RM,Fraser VJ,Kollef MH.Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.Antimicrobial Agents & Chemotherapy. 2005;49:1306-11.
11. Michel P,Quenon JL,de Sarasqueta AM,Scemama O.Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals.British Medical Journal. 2004;328:199.
12. Michel P,Quenon JL,Djihoud A,Tricaud-Vialle S,de Sarasqueta AM.French national survey of inpatient adverse events prospectively assessed with ward staff.BMJ Quality & Safety. 2007;16:369-77.
13. Schlackow I,Stoesser N,Walker AS,Crook DW,Peto TE,Wyllie DH.Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011.Journal of Antimicrobial Chemotherapy. 2012;67:1514-24.
14. Underwood J,Klein JL,Newsholme W.Escherichia coli bacteraemia: how preventable is it?.Journal of Hospital Infection. 2011;79:364-5.